Pregnancy and pregnancy outcome in hepatitis C type 1b

QJM. 2000 Sep;93(9):597-601. doi: 10.1093/qjmed/93.9.597.

Abstract

A large cohort of rhesus-negative women in Ireland were inadvertently infected with hepatitis C virus following exposure to contaminated anti-D immunoglobulin in 1977-8. This major iatrogenic episode was discovered in 1994. We studied 36 women who had been infected after their first pregnancy, and compared them to an age- and parity-matched control group of rhesus-positive women. The presence of hepatitis C antibody was confirmed in all 36 by enzyme-linked immunosorbent assay and by recombinant immunoblot assay, while 26 (72%) of the cohort were HCV-RNA-positive (type 1b) on PCR testing. In the 20 years post-infection, all members of the study group had at least one pregnancy, and mean parity was 3.5. They had a total of 100 pregnancies and 85 of these went to term. There were four premature births, one being a twin pregnancy, and 11 spontaneous miscarriages. One miscarriage occurred in the pregnancy following HCV infection. There were two neonatal deaths due to severe congenital abnormalities in the PCR-positive women. Of the children born to HCV-RNA positive mothers, only one (2.3%) tested positive for the virus. Significant portal fibrosis on liver biopsy was confined to HCV-RNA-positive mothers apart from one single exception in the antibody-positive HCV-RNA-negative group. Comparison with the control group showed no increase in spontaneous miscarriage rate, and no significant difference in obstetric complications; birth weights were similar for the two groups.

MeSH terms

  • Adult
  • Case-Control Studies
  • Congenital Abnormalities
  • Female
  • Fetal Death
  • Fibrosis
  • Hepacivirus / genetics
  • Hepatitis C, Chronic*
  • Humans
  • Iatrogenic Disease*
  • Infant, Newborn
  • Infant, Premature
  • Infectious Disease Transmission, Vertical
  • Liver / pathology
  • Parity
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • RNA, Viral / blood
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rh Isoimmunization / therapy
  • Rho(D) Immune Globulin / administration & dosage
  • Twins

Substances

  • RNA, Viral
  • Rho(D) Immune Globulin